Skip to main content
  • En
  • Français

Top Navigation

  • Newsroom
  • Contact Us

Main navigation

  • About Us
  • Products
  • Technology
  • Clinical Studies
  • Investors
  • News
  • En
  • Français
BioSenic - Investors

Investors

Financial Calendar

26 October 2023
Q3 2023 Business and Financial Highlights
07 September 2023
Half Year Results 2023
14 June 2023
Annual General Meeting 2023
22 May 2023
Q1 2023 Business and Financial Highlights
27 April 2023
Full Year Results & Annual Report 2022

This schedule is indicative and subject to change.
The Annual General Meeting date has been modified to be in line with the Company’s Articles of Associations.
The Q1 2023 Business and Financial Highlights date has been advanced to 22 May 2023

BioSenic was formed through a reverse merger between Bone Therapeutics and Medsenic. All financial information can be found below.

Shareholder Information

SHAREHOLDER STRUCTURE

Share holders structure

SHARE INFORMATION

BioSenic's shares were listed on the regulated market of Euronext Brussels and Euronext Paris on February 6, 2015 under the symbol BIOS.

As of October 17, 2023, BioSenic has a total number of 163,181,474 outstanding shares.

 

BIOS EURONEXT elligible PEA PME

 

ANALYSTS COVERAGE

Portzamparc

Analyst : Clément Bassat

Price Target : 0,52 € on 14/02/2023

 

Gilbert Dupont

Analyst : Pierre-Alexandre Desir

Price Target : 0,21 € on 14/02/2023

 

 

Corporate Governance

Corporate Governance Charter
Dealing Code
Articles of association

IR Contact

Alexia Rieger, CIRO, Chief Investor Relation Officer 

BioSenic SA
Rue Granbonpré 11 – Bâtiment H (bte 24)
1435 Mont-St-Guibert – Belgium
T.: +32 493 09 73 66
investorrelations@biosenic.com

 

Stock information

BioSenic ( BIOS )

0.061€

08.12.2023

Wallonie Eu Flag

BioSenic SA
Rue Granbonpré 11 – Bâtiment H (bte 24)
1435 Mont-St-Guibert – Belgium
T.: +32 493 09 73 66
info@biosenic.com
Contact

Sign upfor our press releases

Receive information about BioSenic

Sign Up

Footer menu

  • Privacy Policy
  • Trademarks Copyrights
  • Users conditions